MedPath

SANDOZ PRIVATE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

PHILIPPINES:17
SFDA:5
NMPA:4

Drug Approvals

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字HJ20240054
Approval Date
Jun 28, 2024
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字HJ20240052
Approval Date
Jun 28, 2024
NMPA

Sitagliptin Phosphate Tablets

Product Name
磷酸西格列汀片
Approval Number
国药准字HJ20240053
Approval Date
Jun 28, 2024
NMPA

Montelukast Sodium Tablets

Product Name
孟鲁司特钠片
Approval Number
国药准字HJ20210076
Approval Date
Nov 3, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.